首页 | 本学科首页   官方微博 | 高级检索  
     

BRCA1和p120ctn在乳腺浸润性导管癌中的表达及其临床意义
引用本文:南润玲|尚培中|朱习琴. BRCA1和p120ctn在乳腺浸润性导管癌中的表达及其临床意义[J]. 中国普通外科杂志, 2012, 21(5): 558-562
作者姓名:南润玲|尚培中|朱习琴
作者单位:河北北方学院;解放军第二五一医院普通外科
摘    要:目的:观察乳腺浸润性导管癌组织中BRCA1和p120ctn表达及其与临床病理特征之间的关系,探讨它们在乳腺浸润性导管癌发生、发展中的作用及临床应用价值。方法:采用免疫组化方法,检测BRCA1蛋白及p120ctn在乳腺浸润性导管癌、乳腺腺病和癌旁正常组织的表达。分析两者的表达与各病理特征的关系及其两者的相关性。结果:在60例乳腺浸润性导管中,BRCA1蛋白及p120ctn阳性率分别为60.0%(36/60)和35.0%(21/60),分别低于各自在乳腺腺病和癌旁正常组织中的表达(均P<0.05);BRCA1蛋白表达状态与患者高发病年龄、临床病理分期、伴有腋淋巴结转移以及组织学分级有关(均P<0.05),而与肿瘤大小无关(P>0.05);p120ctn表达状态与临床病理分期、伴有腋淋巴结转移以及组织学分级有关(均P<0.05),而与发病年龄、肿瘤大小无关(均P>0.05);BRCA1蛋白与p120ctn在乳腺浸润性导管癌组织中的表达呈正相关(r=0.314,P<0.05)。结论:BRCA1与p120ctn的联合检测可作为乳腺浸润性导管癌诊断、恶性程度及预后判断的指标,为临床个体化治疗提供依据。

关 键 词:癌,导管,乳腺  BRCA1蛋白质  p120-catenin  免疫组织化学
收稿时间:2011-10-24
修稿时间:2012-04-17

Expression of BRCA1 and p120-catenin in invasive ductal carcinoma of breast and its clinical significance
NAN Runling,SHANG Peizhong,ZHU Xiqin. Expression of BRCA1 and p120-catenin in invasive ductal carcinoma of breast and its clinical significance[J]. Chinese Journal of General Surgery, 2012, 21(5): 558-562
Authors:NAN Runling  SHANG Peizhong  ZHU Xiqin
Affiliation:1.Hebei Beifang Collgeg,Zhangjiakou,Hebei 075000,China;2.Department of General Surgery,the 251st Hospital of PLA,Zhangjiakou,Hebei 075001,China)
Abstract:Objective:To investigate the expressions of breast cancer susceptibility gene 1(BRCA1) protein and p120-catenin(p120ctn) in invasive ductal carcinoma(IDC) of the breast and their relations with the clinicopathologic characteristics of this tumor,so as to determine their roles in the occurrence and development of IDC and their clinical application values. Methods:The expression of BRCA1 protein and p120ctn in the specimens of IDC,breast adenosis and tumor adjacent breast tissue were detected by immunohistochemical method.The relations of both expressions with the various clinicopathologic characteristics of IDC and correlation between the both were analyzed. Results:Among the 60 cases of IDC specimens,the positive expression rates of BRCA1 protein and P120ctn were 60.0%(36/60) and 35.0%(21/60),and both expressions were significantly lower than those in the breast adenosis and tumor adjacent breast tissues,respectively(all P<0.05).The expression status of BRCA1 protein was related to high incidence age,clinical stage,presence of axillary lymph node metastases and histological grade of the patients(all P<0.05),but unrelated to their tumor size(P>0.05).The expression status of p120ctn was relevant to the clinical stage,presence of axillary lymph node metastases and histological grade of the patients(all P<0.05),but irrelevant to their age at onset of disease and tumor size(both P>0.05).There was a positive correlation between the expression of BRCA1 protein and p120ctn in IDC tissues(r=0.314,P<0.05). Conclusion:The combination detection of BRCA1 protein and p120ctn can be used for diagnosis and determination of the degree of malignancy and prognosis of IDC,and provide a basis for the individualized treatment of IDC patients.
Keywords:Carcinoma,Ductal,Breast  BRCA1 Protein  P120-catetin  Immunohistochemistry
本文献已被 CNKI 等数据库收录!
点击此处可从《中国普通外科杂志》浏览原始摘要信息
点击此处可从《中国普通外科杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号